Nam, S., Chen, X., Lim, J., Kim, S., Kim, S., Cho, Y., … Park, S. (2011). In vivo fluorescence imaging of bacteriogenic cyanide in the lungs of live mice infected with cystic fibrosis pathogens. PloS One, 6(7), e21387. https://doi.org/10.1371/journal.pone.0021387 (Original work published 2011)

Lim, J., Lee, K., Kim, S., Kim, Y., Kim, S., Park, W., & Park, S. (1969). YkgM and ZinT proteins are required for maintaining intracellular zinc concentration and producing curli in enterohemorrhagic Escherichia coli (EHEC) O157:H7 under zinc deficient conditions. International Journal of Food Microbiology. https://doi.org/10.1016/j.ijfoodmicro.2011.06.017 (Original work published)

Jo, Y., Kim, S., Koh, K., Park, J., Shim, Y., Lim, J., … Han, K. (2011). Reliable, accurate determination of the leukocyte differential of leukopenic samples by using hematoflow method. The Korean Journal of Laboratory Medicine, 31(3), 131-7. https://doi.org/10.3343/kjlm.2011.31.3.131 (Original work published 2011)

Lee, J., Lim, J., Chung, Y., Chung, S., Park, I., Kim, C., & You, J. (2018). Targeted Temperature Management at 33°C or 36°C Produces Equivalent Neuroprotective Effects in the Middle Cerebral Artery Occlusion Rat Model of Ischemic Stroke. Shock (Augusta, Ga.). https://doi.org/10.1097/SHK.0000000000001106 (Original work published 2018)

Sakimoto, K., Kornienko, N., Cestellos-Blanco, S., Lim, J., Liu, C., & Yang, P. (2018). Physical Biology of the Materials-Microorganism Interface. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.7b11135 (Original work published 2018)

Pivot, X., Bondarenko, I., Nowecki, Z., Dvorkin, M., Trishkina, E., Ahn, J., … Lim, J. (2018). Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive... Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2017740126. https://doi.org/10.1200/JCO.2017.74.0126 (Original work published 2018)

Reilley, M., Bailey, A., , Janku, F., Naing, A., Falchook, G., … Hong, D. Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. Journal for Immunotherapy of Cancer, 5, 35. https://doi.org/10.1186/s40425-017-0238-1 (Original work published 2017)